Literature DB >> 3207559

The immunological basis of adverse drug reactions. A report on a symposium held in Liverpool on 6th April 1988.

B K Park1, J W Coleman.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 3207559      PMCID: PMC1386624          DOI: 10.1111/j.1365-2125.1988.tb05287.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  16 in total

Review 1.  Drug disposition and drug hypersensitivity.

Authors:  B K Park; J W Coleman; N R Kitteringham
Journal:  Biochem Pharmacol       Date:  1987-03-01       Impact factor: 5.858

Review 2.  Halothane hepatitis: a model of immune mediated drug hepatotoxicity.

Authors:  J Neuberger; J G Kenna
Journal:  Clin Sci (Lond)       Date:  1987-03       Impact factor: 6.124

3.  Effect of storage of penicillin-G solutions on sensitisation to penicillin-G after intravenous administration.

Authors:  K A Neftel; M Wälti; H Spengler; A L de Weck
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

4.  Drug-protein conjugates--XV. A study of the disposition of D-penicillamine in the rat and its relationship to immunogenicity.

Authors:  J W Coleman; A L Foster; J H Yeung; B K Park
Journal:  Biochem Pharmacol       Date:  1988-02-15       Impact factor: 5.858

5.  Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis.

Authors:  J Neuberger; G Mieli-Vergani; J M Tredger; M Davis; R Williams
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

6.  Drugs that induce systemic lupus erythematosus inhibit complement component C4.

Authors:  E Sim; E W Gill; R B Sim
Journal:  Lancet       Date:  1984-08-25       Impact factor: 79.321

7.  Specific sensitization of Lyt-1+2- T cells to spleen cells modified by the drug D-penicillamine or a stereoisomer.

Authors:  N Nagata; U Hurtenbach; E Gleichmann
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

8.  Drug-protein conjugates--X. The role of protein conjugation in the disposition of dinitrofluorobenzene.

Authors:  J L Maggs; N R Kitteringham; P S Grabowski; B K Park
Journal:  Biochem Pharmacol       Date:  1986-02-01       Impact factor: 5.858

9.  Hydralazine binds covalently to complement component C4. Different reactivity of C4A and C4B gene products.

Authors:  E Sim; S K Law
Journal:  FEBS Lett       Date:  1985-05-20       Impact factor: 4.124

10.  Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.

Authors:  J A Mitchell; J R Batchelor; H Chapel; C N Spiers; E Sim
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

View more
  2 in total

Review 1.  [Detection and evaluation of adverse drug reactions].

Authors:  P A Thürmann; K Schmitt
Journal:  Med Klin (Munich)       Date:  1998-11-15

Review 2.  The epidemiology of serious adverse drug reactions among the elderly.

Authors:  P A Atkin; P C Veitch; E M Veitch; S J Ogle
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.